A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade

REFERENCES

• Watts R, Scott DGI. Polyarteritis nodosa and microscopic poly-angiitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th ed. Philadelphia: Elsevier Mosby; 2011. p. 1523–33.
   Google Scholar
• Bastian HM. Cutaneous polyarteritis. In: Ball GV, Bridges SL, editors. Vasculitis. 2nd ed. New York: Oxford University Press; 2008. p. 365–72.
   Google Scholar
• Ishiguro N, Kawashima M. Cutaneous polyarteritis nodosa: a report of 16 cases with clinical and histopathological analysis and a review of the published work. J Dermatol. 2010;37:85–93.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Kanazawa N, Ikeda T, Yamamoto Y, Nakabayashi K, Ozaki S, et al. Cutaneous polyarteritis nodosa: revisiting its defini-tion and diagnostic criteria. Arch Dermatol Res. 2009;301:117–21.
   PubMed Web of Science ®Google Scholar
• Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol. 1997;136: 706–13.
   Google Scholar
• Minkowitz G, Smoller BR, McNutt NS. Benign cutaneous pol-yarteritis nodosa. Relationship to systemic polyarteritis nodosa and to hepatitis B infection. Arch Dermatol. 1991;127:1520–3.
   Google Scholar
• Whittaker SJ, Dover JS, Greaves MW. Cutaneous polyarteritis nodosa associated with hepatitis B surface antigen. J Am Acad Dermatol. 1986;15:1142–5.
   Google Scholar
• Morgan AJ, Schwartz RA. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol. 2010;49:750–6.
   PubMed Web of Science ®Google Scholar
• Bauzd A, Espana A, Idoate M. Cutaneous polyarteritis nodosa. Br J Dermatol. 2002;146:694–9.
   Google Scholar
• Kluger N, Guillot B, Bessis D. Ulcerative cutaneous polyarteritis nodosa treated with mycophenolate mofetil and pentoxifylline. J Dermatol Treat. 2011;22:175–7.
   Google Scholar
• Diaz-Pérez JL, De Lagrin ZM, Diaz-Ramon JL, Winkelmann RK. Cutaneous polyarteritis nodosa. Semin Cutan Med Surg. 2007;26:77–86.
   PubMedGoogle Scholar
• Arkin A. A clinical and pathological study of periarteritis nodosa: a report of five cases, one histologically healed. Am J Pathol. 1930;6:401–26.
   PubMedGoogle Scholar
• Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–93.
   PubMed Web of Science ®Google Scholar
• Diaz-Pérez JL, Schroeter AL, Winkelmann RK. Cutaneous per-iarteritis nodosa: immunofluorescence studies. Arch Dermatol. 1980;116:56–8.
   Google Scholar
• Van de Pette JE, Jarvis JM, Wilton JM, MacDonald DM. Cuta-neous periarteritis nodosa. Hepatitis B surface antigen-containing immunocomplexes and polymorphonuclear-leukocyte lysosomal enzyme release. Arch Dermatol. 1984;120:109–11.
   Google Scholar
• Keystone EC. The utility of tumour necrosis factor blockade in orphan diseases. Ann Rheum Dis. 2004;63:79–83.
   Google Scholar
• Dharmapalaiah C, Watts RA. The role of biologics in treatment of ANCA-associated vasculitis. Mod Rheumatol. 2011.
   Google Scholar
• The Wegener's Granulomatosis Etanercept (WGET) Research Group. Etanercept plus standard therapy for Wegener's granu-lomatosis. N Engl J Med. 2005;352:351–61.
   Google Scholar
• Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, et al. Biologic therapy in primary systemic vasculitis of the young. Rheumatology. 2009;48:978–86.
   PubMed Web of Science ®Google Scholar
• Feinstein J, Arroyo R. Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade. J Clin Rheumatol. 2005;11:219–22.
   PubMedGoogle Scholar
• Vega Gutierrez J, Rodriguez Prieto MA, Garcia Ruiz JM. Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab. J Eur Acad Dermatol Venereol. 2007;21: 570–1.
   PubMedGoogle Scholar
• Urata Y, Uesato R, Tanaka D, Kowatari K, Nitobe T, Nakamura Y, et al. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients. Mod Rheumatol. 2011;21: 16–23.
   PubMed Web of Science ®Google Scholar
• Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, et al. Kinetics of viral loads and risk of hepatitis B virus reacti-vation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumor necrosis factor alpha therapy. Ann Rheum Dis. 2011;70:1719–25.
   PubMed Web of Science ®Google Scholar